TrialAdvances in therapy2021

Mapping Migraine-Specific Quality of Life to Health State Utilities in Patients Receiving Rimegepant.

Karissa M Johnston et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.